Bactiquant A/S
CSE:BACTIQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.34
7.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bactiquant A/S
Total Equity
Bactiquant A/S
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bactiquant A/S
CSE:BACTIQ
|
Total Equity
kr14.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hove A/S
CSE:HOVE
|
Total Equity
kr71.4m
|
CAGR 3-Years
50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aquaporin A/S
CSE:AQP
|
Total Equity
kr141.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hydract A/S
CSE:HYDRCT
|
Total Equity
kr28.7m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Glunz & Jensen Holding A/S
CSE:GJ
|
Total Equity
kr101.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
F
|
Fom Technologies A/S
CSE:FOM
|
Total Equity
kr73.2m
|
CAGR 3-Years
84%
|
CAGR 5-Years
106%
|
CAGR 10-Years
N/A
|
|
Bactiquant A/S
Glance View
BactiQuant A/S engages in the business to business sale of technology that focuses on handling of water. Bactiquant operates through seven business segments: Aquaculture, Water Utility, Industry, Data Centres, Oil and Gas, Legionella Risk Assessment and Research Institutions. The firm serves customers that come from such industries as public water utility companies, industries needing water cooling or requiring wastewater treatment, as well as aquaculture and operates in five continents.
See Also
What is Bactiquant A/S's Total Equity?
Total Equity
14.4m
DKK
Based on the financial report for Dec 31, 2023, Bactiquant A/S's Total Equity amounts to 14.4m DKK.
What is Bactiquant A/S's Total Equity growth rate?
Total Equity CAGR 5Y
6%
Over the last year, the Total Equity growth was 1%. The average annual Total Equity growth rates for Bactiquant A/S have been 17% over the past three years , 6% over the past five years .
You don't have any saved screeners yet